Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)

Summary

The purpose of this study is to assess the safety, tolerance, pharmacokinetics, and pharmacodynamics of sobetirome, a selective thyroid hormone analog, in adult male X-ALD patients.

Timeline

Start

2013-04

Primary completion

2013-09

Completion

2014-02

Outcome

Outcome not reported

Stopped: “revisions to original study protocol underway”

Drugs

Indications